At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 15 enrolled
Drug / intervention
Electro Flo 5000 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of the Airway Clearance Efficacy of Electro Flo 5000 and Vest Therapy in
In Brief
A Phase 4 clinical trial evaluating Electro Flo 5000 and Incourage Vest System for Cystic Fibrosis. Completed, enrolled 15 participants.
Detailed Summary
It is the goal of the proposed study to compare the efficacy, as assessed primarily by sputum weight, of these two different devices (the Electroflo 500 and VEST therapy) for airway clearance (AC) in CF patients with mild to moderate lung disease, who have stable lung health and perform AC at home as part of their routine therapeutic regimen.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2012
Primary CompletionApr 2013
First PostedOct 2014
TodayJul 2026
First PostedOct 29, 2014
Enrollment StartApr 1, 2012
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.7 years ago
Interventions
Electro Flo 5000device
Airway clearance device
Incourage Vest Systemdevice
Airway Clearance Device